Stock Photo - 01 April 2020, Lower Saxony, Brunswick: Thomas Schirrmann (l-r), managing director of Yumab GmbH, and Andre Frenzel, scientific director of Yumab GmbH, are standing in the laboratory of the life science company. The start-up company conducts research into the development of human antibodies and is thus trying to develop drugs against Covid-19. Photo: Ole Spata/dpa. - Brunswick/Lower Saxony/Germany

Stock Photo: 01 April 2020, Lower Saxony, Brunswick: Thomas Schirrmann (l-r), managing director of Yumab GmbH, and Andre Frenzel, scientific director of Yumab GmbH.

Searchable keywords

Choose multiple keywords